Run 69: https://www.merck.com/
GLEIF on - status: done - case: merck
6 Products
343 LLM calls, 273480 tokens, 0 pages - finished 2026-11-12 05:09 UTC
- Pages read: 10 in 12 calls; left out by the bound: 3
- Offerings: 124 (121 product, 3 service), 65 with a commodity; items dropped (quote not on the page): 0; fields dropped: 0; aspects dropped: 0
- Aspects: 1 unregistered
- Relations not stated (no quote, another maker named, or not confirmed): 0; not attributed to a subject: 0; extraction statements attached: 125
| Offering | Kind | Relation | Owner | Commodity | Quote |
|---|---|---|---|---|---|
| ANTIVENIN™ (LATRODECTUS MACTANS) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51172309 | ANTIVENIN™ (LATRODECTUS MACTANS)https://www.merck.com/products/ |
| BCG Vaccine (For Percutaneous Use) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201647 | BCG Vaccine (For Percutaneous Use)https://www.merck.com/products/ |
| BELSOMRA® (suvorexant) tablets, for oral use, C-IV | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | BELSOMRA® (suvorexant) tablets, for oral use, C-IVhttps://www.merck.com/products/ | |
| BRIDION® (sugammadex) Injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51172328 | BRIDION® (sugammadex) Injection, for intravenous usehttps://www.merck.com/products/ |
| CANCIDAS® (caspofungin acetate) for Injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51283107 | CANCIDAS® (caspofungin acetate) for Injection, for intravenous usehttps://www.merck.com/products/ |
| CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201615 | CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine)https://www.merck.com/products/ |
| DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343816 | DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral usehttps://www.merck.com/products/ |
| DIFICID® (fidaxomicin) for Oral Suspension | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | DIFICID® (fidaxomicin) for Oral Suspensionhttps://www.merck.com/products/ | |
| DIFICID® (fidaxomicin) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | DIFICID® (fidaxomicin) tablets, for oral usehttps://www.merck.com/products/ | |
| EMEND® (aprepitant) capsules (aprepitant) for oral suspension | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51171800 | EMEND® (aprepitant) capsules (aprepitant) for oral suspensionhttps://www.merck.com/products/ |
| EMEND® (fosaprepitant) for injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51171838 | EMEND® (fosaprepitant) for injection, for intravenous usehttps://www.merck.com/products/ |
| ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular usehttps://www.merck.com/products/ | |
| ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201660 | ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injectionhttps://www.merck.com/products/ |
| GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201600 | GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]https://www.merck.com/products/ |
| GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Suspension for intramuscular injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Suspension for intramuscular injectionhttps://www.merck.com/products/ | |
| IDVYNSO™ (doravirine and islatravir) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343800 | IDVYNSO™ (doravirine and islatravir) tablets, for oral usehttps://www.merck.com/products/ |
| INVANZ® (ertapenem for injection) for intravenous (IV) or intramuscular (IM) use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51284603 | INVANZ® (ertapenem for injection) for intravenous (IV) or intramuscular (IM) usehttps://www.merck.com/products/ |
| ISENTRESS® (raltegravir) chewable tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343201 | ISENTRESS® (raltegravir) chewable tablets, for oral usehttps://www.merck.com/products/ |
| ISENTRESS® (raltegravir) film-coated tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343201 | ISENTRESS® (raltegravir) film-coated tablets, for oral usehttps://www.merck.com/products/ |
| ISENTRESS® (raltegravir) for oral suspension | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343201 | ISENTRESS® (raltegravir) for oral suspensionhttps://www.merck.com/products/ |
| ISENTRESS® HD (raltegravir) film-coated tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343201 | ISENTRESS® HD (raltegravir) film-coated tablets, for oral usehttps://www.merck.com/products/ |
| JANUMET® (sitagliptin and metformin hydrochloride) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51182709 | JANUMET® (sitagliptin and metformin hydrochloride) tablets, for oral usehttps://www.merck.com/products/ |
| JANUMET® XR (sitagliptin and metformin hydrochloride extended-release) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51182709 | JANUMET® XR (sitagliptin and metformin hydrochloride extended-release) tablets, for oral usehttps://www.merck.com/products/ |
| JANUVIA® (sitagliptin) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51183303 | JANUVIA® (sitagliptin) tablets, for oral usehttps://www.merck.com/products/ |
| KEYTRUDA® (pembrolizumab) injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | KEYTRUDA® (pembrolizumab) injection, for intravenous usehttps://www.merck.com/products/ | |
| KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous usehttps://www.merck.com/products/ | |
| LIPFENDRA® (enlicitide) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51321800 | LIPFENDRA® (enlicitide) tablets, for oral usehttps://www.merck.com/products/ |
| M-M-R® II [MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE] | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201628 | M-M-R® II [MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE]https://www.merck.com/products/ |
| NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspension | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51303400 | NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspensionhttps://www.merck.com/products/ |
| OHTUVAYRE™(ensifentrine) inhalation suspension, for oral inhalation use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51161700 | OHTUVAYRE™(ensifentrine) inhalation suspension, for oral inhalation usehttps://www.merck.com/products/ |
| Liquid Pedvax HIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201627 | Liquid Pedvax HIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)]https://www.merck.com/products/ |
| PIFELTRO® (doravirine) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343000 | PIFELTRO® (doravirine) tablets, for oral usehttps://www.merck.com/products/ |
| PNEUMOVAX® 23 [pneumococcal vaccine polyvalent] Sterile, Liquid Vaccine for Intramuscular or Subcutaneous Injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201615 | PNEUMOVAX® 23 [pneumococcal vaccine polyvalent] Sterile, Liquid Vaccine for Intramuscular or Subcutaneous Injectionhttps://www.merck.com/products/ |
| PREVYMIS® (letermovir) injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343100 | PREVYMIS® (letermovir) injection, for intravenous usehttps://www.merck.com/products/ |
| PREVYMIS® (letermovir) oral pellets | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343000 | PREVYMIS® (letermovir) oral pelletshttps://www.merck.com/products/ |
| PREVYMIS® (letermovir) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343000 | PREVYMIS® (letermovir) tablets, for oral usehttps://www.merck.com/products/ |
| PRIMAXIN® I.V. (imipenem and cilastatin) for Injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51284903 | PRIMAXIN® I.V. (imipenem and cilastatin) for Injection, for intravenous usehttps://www.merck.com/products/ |
| ProQuad® [Measles, Mumps, Rubella and Varicella Virus Vaccine Live] Lyophilized preparation for subcutaneous injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201648 | ProQuad® [Measles, Mumps, Rubella and Varicella Virus Vaccine Live] Lyophilized preparation for subcutaneous injectionhttps://www.merck.com/products/ |
| RECARBRIO® (imipenem, cilastatin, and relebactam) for injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51284903 | RECARBRIO® (imipenem, cilastatin, and relebactam) for injection, for intravenous usehttps://www.merck.com/products/ |
| RECOMBIVAX HB® [HEPATITIS B VACCINE (RECOMBINANT)] | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201607 | RECOMBIVAX HB® [HEPATITIS B VACCINE (RECOMBINANT)]https://www.merck.com/products/ |
| RotaTeq® [Rotavirus Vaccine, Live, Oral, Pentavalent] Oral Solution | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201618 | RotaTeq® [Rotavirus Vaccine, Live, Oral, Pentavalent] Oral Solutionhttps://www.merck.com/products/ |
| SEGLUROMET® (ertugliflozin and metformin) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51183505 | SEGLUROMET® (ertugliflozin and metformin) tablets, for oral usehttps://www.merck.com/products/ |
| SIVEXTRO® (tedizolid phosphate) for injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51283300 | SIVEXTRO® (tedizolid phosphate) for injection, for intravenous usehttps://www.merck.com/products/ |
| SIVEXTRO® (tedizolid phosphate) tablet, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51283300 | SIVEXTRO® (tedizolid phosphate) tablet, for oral usehttps://www.merck.com/products/ |
| STEGLATRO® (ertugliflozin) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | STEGLATRO® (ertugliflozin) tablets, for oral usehttps://www.merck.com/products/ | |
| STEGLUJAN® (ertugliflozin and sitagliptin) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51183300 | STEGLUJAN® (ertugliflozin and sitagliptin) tablets, for oral usehttps://www.merck.com/products/ |
| STROMECTOL® (IVERMECTIN) TABLETS | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51452801 | STROMECTOL® (IVERMECTIN) TABLETShttps://www.merck.com/products/ |
| TEMODAR® (temozolomide) Capsules and Injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51112902 | TEMODAR® (temozolomide) Capsules and Injectionhttps://www.merck.com/products/ |
| TICE® BCG BCG LIVE (FOR INTRAVESICAL USE) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201647 | TICE® BCG BCG LIVE (FOR INTRAVESICAL USE)https://www.merck.com/products/ |
| VAQTA® [Hepatitis A Vaccine, Inactivated] | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201626 | VAQTA® [Hepatitis A Vaccine, Inactivated]https://www.merck.com/products/ |
| VARIVAX® [Varicella Virus Vaccine Live] | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201624 | VARIVAX® [Varicella Virus Vaccine Live]https://www.merck.com/products/ |
| VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201621 | VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine)https://www.merck.com/products/ |
| VAXNEUVANCE® (Pneumococcal 15 valent Conjugate Vaccine) Suspension for Intramuscular Injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201615 | VAXNEUVANCE® (Pneumococcal 15 valent Conjugate Vaccine) Suspension for Intramuscular Injectionhttps://www.merck.com/products/ |
| VERQUVO® (vericiguat) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51124500 | VERQUVO® (vericiguat) tablets, for oral usehttps://www.merck.com/products/ |
| WELIREG® (belzutifan) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | WELIREG® (belzutifan) tablets, for oral usehttps://www.merck.com/products/ | |
| WINREVAIR™ (sotatercept-csrk) for injection, for subcutaneous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | WINREVAIR™ (sotatercept-csrk) for injection, for subcutaneous usehttps://www.merck.com/products/ | |
| ZEPATIER® (elbasvir and grazoprevir) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343800 | ZEPATIER® (elbasvir and grazoprevir) tablets, for oral usehttps://www.merck.com/products/ |
| ZERBAXA® (ceftolozane and tazobactam) for injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51285004 | ZERBAXA® (ceftolozane and tazobactam) for injection, for intravenous usehttps://www.merck.com/products/ |
| ZINPLAVA™ (bezlotoxumab) injection, for intravenous use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | ZINPLAVA™ (bezlotoxumab) injection, for intravenous usehttps://www.merck.com/products/ | |
| ZOLINZA® (vorinostat capsules, for oral use) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | ZOLINZA® (vorinostat capsules, for oral use)https://www.merck.com/products/ | |
| Merck Patient Assistance Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/products/ | |
| Merck Access Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | [Merck Access Program](https://www.merckaccessprogram.com/) Information about insurance coverage and financial assistance options for eligible patients.https://www.merck.com/products/ | |
| OHTUVAYRE® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | OHTUVAYRE®https://www.merck.com/research/product-pipeline/ | |
| MK-2010 | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | MK-2010https://www.merck.com/research/product-pipeline/ | |
| ENFLONSIA™ | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | ENFLONSIA™https://www.merck.com/research/product-pipeline/ | |
| MK-1045 | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | MK-1045https://www.merck.com/research/product-pipeline/ | |
| MK-8690 | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | MK-8690https://www.merck.com/research/product-pipeline/ | |
| efitazanamivir alfa | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51341901 | efitazanamivir alfahttps://www.merck.com/research/product-pipeline/ |
| MK-7262 | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | MK-7262https://www.merck.com/research/product-pipeline/ | |
| gocatamig | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | gocatamighttps://www.merck.com/research/product-pipeline/ | |
| ensifentrine (+) glycopyrrolate | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | ensifentrine (+) glycopyrrolatehttps://www.merck.com/research/product-pipeline/ | |
| IDVYNSO™ | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | IDVYNSO™https://www.merck.com/research/product-pipeline/ | |
| MK-2214 | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | MK-2214https://www.merck.com/research/product-pipeline/ | |
| MK-8748 | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | MK-8748https://www.merck.com/research/product-pipeline/ | |
| remigromig | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | remigromighttps://www.merck.com/research/product-pipeline/ | |
| calderasib | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | calderasibhttps://www.merck.com/research/product-pipeline/ | |
| raludotatug deruxtecan | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | raludotatug deruxtecanhttps://www.merck.com/research/product-pipeline/ | |
| alimatravir | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51342500 | alimatravirhttps://www.merck.com/research/product-pipeline/ |
| patritumab deruxtecan | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | patritumab deruxtecanhttps://www.merck.com/research/product-pipeline/ | |
| ifinatamab deruxtecan | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | ifinatamab deruxtecanhttps://www.merck.com/research/product-pipeline/ | |
| tulisokibart | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | tulisokibarthttps://www.merck.com/research/product-pipeline/ | |
| bomedemstat | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | bomedemstathttps://www.merck.com/research/product-pipeline/ | |
| KEYTRUDA QLEX™ | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51111785 | KEYTRUDA QLEX™https://www.merck.com/research/product-pipeline/ |
| V181 | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | V181https://www.merck.com/research/product-pipeline/ | |
| opevesostat | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | opevesostathttps://www.merck.com/research/product-pipeline/ | |
| sacituzumab tirumotecan | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | sacituzumab tirumotecanhttps://www.merck.com/research/product-pipeline/ | |
| islatravir + lenacapavir | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343800 | islatravir + lenacapavirhttps://www.merck.com/research/product-pipeline/ |
| LIPFENDRA® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51283101 | LIPFENDRA®https://www.merck.com/research/product-pipeline/ |
| WINREVAIR™ | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | WINREVAIR™https://www.merck.com/research/product-pipeline/ | |
| WELIREG™ | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 39121635 | WELIREG™https://www.merck.com/research/product-pipeline/ |
| zilovertamab vedotin | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | zilovertamab vedotinhttps://www.merck.com/research/product-pipeline/ | |
| KEYTRUDA® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | KEYTRUDA®https://www.merck.com/research/product-pipeline/ | |
| efinopegdutide | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51181500 | efinopegdutidehttps://www.merck.com/research/product-pipeline/ |
| LYNPARZA® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | LYNPARZA®https://www.merck.com/research/product-pipeline/ | |
| islatravir + ulonivirine | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343800 | islatravir + ulonivirinehttps://www.merck.com/research/product-pipeline/ |
| intismeran autogene | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | intismeran autogenehttps://www.merck.com/research/product-pipeline/ | |
| LAGEVRIO™ | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343809 | LAGEVRIO™https://www.merck.com/research/product-pipeline/ |
| nemtabrutinib | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51112022 | nemtabrutinibhttps://www.merck.com/research/product-pipeline/ |
| Merck Patient Assistance Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/research/product-pipeline/ | |
| KEYTRUDA® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | KEYTRUDA®https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf | |
| KEYTRUDA QLEX | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | KEYTRUDA QLEXhttps://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf | |
| WELIREG® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 39121635 | WELIREG®https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf |
| WINREVAIR | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | WINREVAIRhttps://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf | |
| LAGEVRIO® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343812 | LAGEVRIO®https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf |
| OHTUVAYRE® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | OHTUVAYRE®https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf | |
| LYNPARZA® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | LYNPARZA®https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf | |
| LIPFENDRA® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51283101 | LIPFENDRA®https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf |
| ENFLONSIA | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | ENFLONSIAhttps://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf | |
| IDVYNSO | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | IDVYNSOhttps://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf | |
| CAPVAXIVE | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | CAPVAXIVEhttps://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf | |
| LIPFENDRA® (enlicitide) tablets | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51321800 | LIPFENDRA® (enlicitide) tablets 20 mghttps://www.merck.com/media/media-library/ |
| CAPVAXIVE™ (Pneumococcal 21-valent conjugate vaccine) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201615 | CAPVAXIVE™ (Pneumococcal 21-valent conjugate vaccine)https://www.merck.com/media/media-library/ |
| IDVYNSO™ (doravirine and islatravir) tablets, for oral use | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51343800 | IDVYNSO™ (doravirine and islatravir) tablets, for oral usehttps://www.merck.com/media/media-library/ |
| ENFLONSIA™ (clesrovimab-cfor) for Injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | ENFLONSIA™ (clesrovimab-cfor) for Injectionhttps://www.merck.com/media/media-library/ | |
| WINREVAIR™ (sotatercept-csrk) for Injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | WINREVAIR™ (sotatercept-csrk) for Injectionhttps://www.merck.com/media/media-library/ | |
| KEYTRUDA QLEX TM (pembrolizumab and berahyaluronidase alfa-pmph) for Injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | KEYTRUDA QLEX TM (pembrolizumab and berahyaluronidase alfa-pmph) for Injectionhttps://www.merck.com/media/media-library/ | |
| KEYTRUDA® (pembrolizumab) Injection | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | KEYTRUDA® (pembrolizumab) Injectionhttps://www.merck.com/media/media-library/ | |
| prescription medicines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, preventive options, biologic therapies and animal health products.https://www.merck.com/media/media-library/ | |
| vaccines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, preventive options, biologic therapies and animal health products.https://www.merck.com/media/media-library/ | |
| biologic therapies | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, preventive options, biologic therapies and animal health products.https://www.merck.com/media/media-library/ | |
| animal health products | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, preventive options, biologic therapies and animal health products.https://www.merck.com/media/media-library/ | |
| Merck Patient Assistance Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/media/media-library/ | |
| Merck Access Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | [Merck Access Program](https://www.merckaccessprogram.com/) Information about insurance coverage and financial assistance options for eligible patients.https://www.merck.com/media/media-library/ | |
| medicines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | research, develop, communicate and sell our medicines, vaccines, and other productshttps://www.merck.com/company-overview/culture-and-values/code-of-conduct/ | |
| vaccines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | research, develop, communicate and sell our medicines, vaccines, and other productshttps://www.merck.com/company-overview/culture-and-values/code-of-conduct/ | |
| adult vaccines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201600 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/company-overview/culture-and-values/code-of-conduct/ |
| Merck Patient Assistance Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/company-overview/culture-and-values/code-of-conduct/ | |
| Merck Access Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | [Merck Access Program](https://www.merckaccessprogram.com/) Information about insurance coverage and financial assistance options for eligible patients.https://www.merck.com/company-overview/culture-and-values/code-of-conduct/ | |
| Merck Manuals | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 83121600 | [Merck Manuals](https://www.merckmanuals.com/) Medical information source covering thousands of topics in all fields of medicine.https://www.merck.com/company-overview/culture-and-values/code-of-conduct/ |
| Efinopegdutide | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51181500 | Merck Announces Positive Results from Phase 2b Trial of Efinopegdutidehttps://www.merck.com/investor-relations/ |
| OHTUVAYRE® (ensifentrine) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Initiates Phase 3 Study Evaluating OHTUVAYRE® (ensifentrine)https://www.merck.com/investor-relations/ | |
| Merck medicines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/investor-relations/ | |
| adult vaccines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201600 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/investor-relations/ |
| Merck Patient Assistance Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/investor-relations/ | |
| Merck Access Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Access Program](https://www.merckaccessprogram.com/) Information about insurance coverage and financial assistance options for eligible patients.https://www.merck.com/investor-relations/ | |
| Merck Manuals | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 83121600 | Merck Manuals](https://www.merckmanuals.com/) Medical information source covering thousands of topics in all fields of medicine.https://www.merck.com/investor-relations/ |
| KEYTRUDA® (pembrolizumab) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | KEYTRUDA® (pembrolizumab)https://www.merck.com/media/ | |
| OHTUVAYRE® (ensifentrine) | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | OHTUVAYRE® (ensifentrine)https://www.merck.com/media/ | |
| Mectizan® | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51452801 | Mectizan®https://www.merck.com/media/ |
| Merck medicines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/media/ | |
| adult vaccines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 51201600 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/media/ |
| Merck Patient Assistance Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/media/ | |
| Merck Access Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | [Merck Access Program](https://www.merckaccessprogram.com/) Information about insurance coverage and financial assistance options for eligible patients.https://www.merck.com/media/ | |
| pharmaceuticals | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck pharmaceuticals and vaccineshttps://www.merck.com/wp-content/uploads/sites/124/2025/03/EOS-Handbook-_March-2025.pdf | |
| vaccines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck pharmaceuticals and vaccineshttps://www.merck.com/wp-content/uploads/sites/124/2025/03/EOS-Handbook-_March-2025.pdf | |
| pharmaceutical products | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | pharmaceutical productshttps://www.merck.com/wp-content/uploads/sites/124/2025/03/EOS-Handbook-_March-2025.pdf | |
| medicines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | development of important medicines and vaccineshttps://www.merck.com/ | |
| vaccines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | development of important medicines and vaccineshttps://www.merck.com/ | |
| Merck Patient Assistance Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/ | |
| Merck Access Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Access Programhttps://www.merck.com/ | |
| Merck Manuals | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 83121600 | Merck Manualshttps://www.merck.com/ |
| medicines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | development of important medicines and vaccineshttps://www.merck.com/company-overview/ | |
| vaccines | product | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | development of important medicines and vaccineshttps://www.merck.com/company-overview/ | |
| Merck Patient Assistance Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.https://www.merck.com/company-overview/ | |
| Merck Access Program | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | [Merck Access Program](https://www.merckaccessprogram.com/) Information about insurance coverage and financial assistance options for eligible patients.https://www.merck.com/company-overview/ | |
| Merck Manuals | service | not stated | Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 | 83121600 | [Merck Manuals](https://www.merckmanuals.com/) Medical information source covering thousands of topics in all fields of medicine.https://www.merck.com/company-overview/ |